Optimizing bevacizumab dosing in glioblastoma: less is more
Crossref DOI link: https://doi.org/10.1007/s11060-017-2553-2
Published Online: 2017-06-30
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ajlan, Abdulrazag http://orcid.org/0000-0003-1725-339X
Thomas, Piia
Albakr, Abdulrahman
Nagpal, Seema
Recht, Lawrence
License valid from 2017-06-30